Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects

NCT00684710 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Healthy

Interventions

DRUG: PAZ-417
DRUG: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer